IVA Inventiva S.A.

NASDAQ
$4.60

Inventiva S.A. (IVA) is confirmed to report earnings on September 25, 2026, after the market close. The consensus earnings estimate is a loss of $0.20 per share.

Earnings Date
2nd Quarter, Jun 2026
Sep 25
Friday · 4:10 PM ET
Earnings Whisper
-
vs ($0.20)
Rev est $6.96M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Inventiva S.A.

Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of NASH, MPS and other diseases with significant unmet medical need.

Sector

Healthcare

Industry

Biotechnology